Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar

J Infect Dis. 2008 May 15;197(10):1427-35. doi: 10.1086/587694.

Abstract

Background: After the 2001-2002 poliomyelitis outbreak due to recombinant vaccine-derived polioviruses (VDPVs) in the Toliara province of Madagascar, another outbreak reoccurred in the same province in 2005.

Methods: We conducted epidemiological and virological investigations for each polio case patient and for their contacts.

Results: From May to August 2005, a total of 5 cases of acute flaccid paralysis were reported among unvaccinated or partially vaccinated children 2-3 years old. Type-3 or type-2 VDPV was isolated from case patients and from healthy contacts. These strains were classified into 4 recombinant lineages that showed complex mosaic genomic structures originating from different vaccine strain serotypes and probably from human enterovirus C (HEV-C) species. Genetic relatedness could be observed among these 4 lineages. Vaccination coverage of the population was very low (<50%).

Conclusions: The broad distribution of VDPVs in the province and their close genetic relationship indicate intense and rapid cocirculation and coevolution of the vaccine strains and of their related HEV-C strains. The occurrence of an outbreak due to VDPV 3 years after a previous outbreak indicates that a short period with low vaccination coverage is enough to create favorable conditions for the emergence of VDPV in this setting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child, Preschool
  • Disease Outbreaks*
  • Enterovirus C, Human / genetics
  • Humans
  • Madagascar / epidemiology
  • Male
  • Phylogeny
  • Poliomyelitis / epidemiology*
  • Poliomyelitis / virology
  • Poliovirus / classification
  • Poliovirus / genetics
  • Poliovirus / isolation & purification
  • Poliovirus Vaccines / adverse effects*
  • Poliovirus Vaccines / isolation & purification
  • RNA, Viral / genetics
  • Recombination, Genetic
  • Sequence Analysis, DNA
  • Vaccines, Synthetic / adverse effects

Substances

  • Poliovirus Vaccines
  • RNA, Viral
  • Vaccines, Synthetic